![Screening, enrolment, randomisation and follow-up of study patients.... | Download Scientific Diagram Screening, enrolment, randomisation and follow-up of study patients.... | Download Scientific Diagram](https://www.researchgate.net/profile/R-Faustino/publication/347194523/figure/fig1/AS:971564736577537@1608650492299/NEDA-3-status-and-its-three-components_Q320.jpg)
Screening, enrolment, randomisation and follow-up of study patients.... | Download Scientific Diagram
![PDF) Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro PDF) Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro](https://i1.rgstatic.net/publication/338992661_Human_CD4_T_cell_subsets_differ_in_their_abilities_to_cross_endothelial_and_epithelial_brain_barriers_in_vitro/links/5e381017299bf1cdb908bead/largepreview.png)
PDF) Human CD4+ T cell subsets differ in their abilities to cross endothelial and epithelial brain barriers in vitro
![PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland](https://i1.rgstatic.net/publication/325133947_Effectiveness_and_safety_of_Rituximab_in_multiple_sclerosis_an_observational_study_from_Southern_Switzerland/links/5afa2b1a458515c00b6bc92f/largepreview.png)
PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
![Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - - European ... Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - - European ...](https://onlinelibrary.wiley.com/cms/asset/84188f30-c534-4f49-a5a8-6769a35bc872/ene15171-fig-0002-m.jpg)
Efficacy and safety of ocrelizumab in patients with relapsing‐remitting multiple sclerosis with suboptimal response to prior disease‐modifying therapies: A primary analysis from the phase 3b CASTING single‐arm, open‐label trial - Vermersch - - European ...
![PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis](https://www.researchgate.net/publication/328533988/figure/fig2/AS:685984891035652@1540562951657/NEDA-3-Left-panel-Percentage-of-patients-treated-with-natalizumab-black-bars-or_Q320.jpg)
PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
![PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis](https://i1.rgstatic.net/publication/328533988_NEDA-3_status_including_cortical_lesions_in_the_comparative_evaluation_of_natalizumab_versus_fingolimod_efficacy_in_multiple_sclerosis/links/5bd32003a6fdcc3a8da7a541/largepreview.png)
PDF) NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis
![PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland](https://www.researchgate.net/publication/325133947/figure/fig2/AS:626348309635073@1526344482064/Proportion-of-RRMS-patients-with-not-evidence-of-disease-activity-NEDA-under-treatment_Q320.jpg)
PDF) Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
![PDF) Abstracts of the 113th Annual Meeting of the Swiss Neurological Society, Congress Centre Kursaal Interlaken, Interlaken, Switzerland, 18–19 November 2021 PDF) Abstracts of the 113th Annual Meeting of the Swiss Neurological Society, Congress Centre Kursaal Interlaken, Interlaken, Switzerland, 18–19 November 2021](https://i1.rgstatic.net/publication/356257435_Abstracts_of_the_113th_Annual_Meeting_of_the_Swiss_Neurological_Society_Congress_Centre_Kursaal_Interlaken_Interlaken_Switzerland_18-19_November_2021/links/6193a6023068c54fa5efa802/largepreview.png)